Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Blend Labs

I Would So Use Options to Play This Top 100 Stock

On Wednesday, Blend Labs joined Barchart.com’s Top 100 Stocks to Buy. Unranked the previous day, the provider of cloud-based banking software jumped into 56th place, up 15% in mid-afternoon trading.

Barchart · Mar 6, 2024

Stocks That Hit 52-Week Lows On Wednesday

On Wednesday, 200 companies hit new 52-week lows.

Benzinga · Oct 19, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

Benzinga · May 25, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Expert Ratings for Blend Labs

Over the past 3 months, 13 analysts have published their opinion on Blend Labs (NYSE:BLND) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · May 13, 2022

Read How Analysts Reacted To Blend Labs' Q4 Results

Analysts mainly slashed the price targets or downgraded the rating on Blend Labs Inc (NYSE:BLND) post Q4 results. KeyBanc analyst Josh Beck lowered the price target to $6 from $10 (26% upside) and kept an Overweight. The company's FY22 revenue forecast was well below the Street's $343.8 million, reflecting the negative impact of higher rates…

Benzinga · Apr 1, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022

Upgrades

Benzinga · Apr 1, 2022

Why Blend Labs Shares Are Plunging After Hours

Blend Labs Inc (NYSE:BLND) reported fourth-quarter revenue growth of 164.3% year-over-year to $80.99 million, missing the consensus of $82.92 million. Blend Platform segment revenue was $36.5 million (+19% Y/Y), and Title365 segment revenue was $44.4 million. EPS was $(0.32), missing the consensus of $(0.19). The adjusted net loss was $(44.35) million, compared…

Benzinga · Mar 31, 2022

Read news from The Economist, FT, and more,
with one subscription

12 Information Technology Stocks Moving In Monday's Intraday Session

Gainers

Benzinga · Mar 21, 2022

Expert Ratings For Blend Labs

Within the last quarter, Blend Labs (NYSE:BLND) has observed the following analyst ratings:

Benzinga · Mar 21, 2022

Where Blend Labs Stands With Analysts

Blend Labs (NYSE:BLND) has observed the following analyst ratings within the last quarter:

Benzinga · Feb 14, 2022

Expert Ratings For Blend Labs

Analysts have provided the following ratings for Blend Labs (NYSE:BLND) within the last quarter:

Benzinga · Jan 25, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Walgreens Boots Alliance

110 stories

Read news from The Economist, FT, and more,
with one subscription

Places

United States

423,320 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.